Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

RGAG4 Activators

The RGAG4 protein is a pivotal component in specific cellular pathways, and its activity can be modulated by various biochemical activators. These activators function through distinct mechanisms that ultimately lead to the increased activity of RGAG4. For instance, certain activators target adenylyl cyclase, directly stimulating it to elevate intracellular cAMP levels. This second messenger plays a critical role in cAMP-dependent pathways, which are known to interact with proteins such as RGAG4, thereby enhancing its cellular function. Similarly, the use of cAMP analogs serves to mimic this effect, providing a sustained activation of these pathways and indirectly promoting the functional activity of RGAG4. Other activators work by increasing intracellular calcium concentrations, either through direct ionophoretic mechanisms or by agonizing calcium channels, which then activate calcium-dependent proteins that can influence the activity of RGAG4.

Beyond the modulation of second messengers, there are activators that affect RGAG4 through alterations in protein phosphorylation. Specific compounds can activate protein kinase C, which has the potential to phosphorylate a range of substrates that interact with RGAG4, thereby influencing its activity. In a similar vein, the inhibition of phosphodiesterases leads to an accumulation of cAMP, which indirectly could result in the enhanced activity of RGAG4. On a different aspect of cellular regulation, some activators disrupt the structural integrity of the Golgi apparatus, influencing intracellular trafficking and signaling pathways that may indirectly affect RGAG4 activity. Additionally, the inhibition of protein phosphatases results in an increased phosphorylation state of various proteins, which could subsequently lead to the activation of RGAG4 through altered signaling dynamics.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Directly stimulates adenylyl cyclase, increasing intracellular cAMP levels which could enhance the activity of RGAG4 through cAMP-dependent pathways.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC), which may phosphorylate substrates that could interact with RGAG4, thus potentially increasing its activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

A beta-adrenergic agonist that increases cAMP levels, potentially enhancing the activity of RGAG4 via cAMP-mediated signaling cascades.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Increases intracellular calcium concentration, which could activate calcium-dependent proteins that modulate the function of RGAG4.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

A calcium ionophore that raises intracellular calcium levels, possibly promoting the activation of RGAG4 through calcium signaling pathways.

8-Bromo-cAMP

76939-46-3sc-201564
sc-201564A
10 mg
50 mg
$97.00
$224.00
30
(1)

A cAMP analog that activates cAMP-dependent pathways, potentially leading to an increase in RGAG4 activity.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$45.00
$130.00
$480.00
$4450.00
74
(7)

A cAMP analog which may activate cAMP-dependent protein kinases that could indirectly increase the activity of RGAG4.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$40.00
$102.00
$197.00
$1739.00
$16325.00
(1)

A hormone and neurotransmitter that can increase cAMP levels through its interaction with adrenergic receptors, possibly enhancing RGAG4 activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

A nonspecific inhibitor of phosphodiesterases that prevents cAMP degradation, possibly leading to increased activity of RGAG4 via elevated cAMP.

(±)-Bay K 8644

71145-03-4sc-203324
sc-203324A
sc-203324B
1 mg
5 mg
50 mg
$82.00
$192.00
$801.00
(0)

A calcium channel agonist that could increase intracellular calcium and indirectly activate RGAG4 through calcium-dependent signaling mechanisms.